News & Events
May 10, 2007
The Predictive Safety Testing Consortium enables companies to share and validate safety biomarkers.To address the issues surrounding a decade-long decrease in the number of new drug approvals, the U.S. Food and Drug Administration (FDA) in 2004 published a report titled Challenge and Opportunity on the Critical Path to New Medical Products....
April 10, 2007
Pharmaceutical Companies and FDA Making StridesDeveloping a new drug is a costly and time-intensive venture. It often takes years to safely develop, test, and ultimately gain Food and Drug Administration approval to bring the drugs to market....
March 10, 2007
C-Path Adopts Rosetta Resolver® System for the PSTCRosetta Biosoftware announced today that The Critical Path Institute (C-Path) adopted the Rosetta Resolver® system for C-Path’s Predictive Safety Testing Consortium....
March 10, 2007
Raymond Woosley, M.D., Ph.D., Provides Expert Testimony in Congressional HearingsPresident and CEO of The Critical Path Institute (C-Path) provided testimony and answered questions about drug development yesterday at the Committee on Energy and Commerce’s Subcommittee Hearing on Oversight and Investigations entitled “The Adequacy of FDA Efforts to Assure the Safety of the Drug Supply.”...
November 10, 2006
Tucson Nonprofit Seeks to Get Cures to Patients FasterA little-noticed 2004 report from the Food and Drug Administration contained a bombshell. Although spending on research and development had been rising for the previous decade, applications for new drugs and medical products had been falling....